As of Mar 24
| -0.07 / -0.20%|
The 4 analysts offering 12-month price forecasts for Repligen Corp have a median target of 37.00, with a high estimate of 39.00 and a low estimate of 30.00. The median estimate represents a +6.81% increase from the last price of 34.64.
The current consensus among 4 polled investment analysts is to Buy stock in Repligen Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.